Answers are grounded in this paper and cite their sources.
Demonstrates that adverse mood effects from oral contraceptives increase risk for reproductive depressive episodes in women, indicating genetic vulnerability.
PURPOSE: This study tested whether adverse mood effect of the oral contraceptive pill (OCP) is associated with reproductive depressive episodes, including peripartum depression (PPD), premenstrual dysphoric disorder (PMDD), and perimenopausal depression. METHOD: In a sample of 3,547 OCP users from the Australian Genetics of Depression Study, who reported a lifetime depression diagnosis, logistic regression was used to test the association of PPD, PMDD, and perimenopausal depression with OCP adverse mood effect. Polygenic scores (PGS) for major depression (MD) were also tested for association with adverse mood effect. Sensitivity analyses tested for modification of these associations by a history of depression prior to first OCP use (prior depression), or by depression onset before the age of twenty (child/teen depression onset). CONCLUSIONS: Participants who experience an adverse mood effect with OCP use are likely to have higher genetic vulnerability for depression, and experience child/teen depression onset, as well as reproductive depressive episodes such as PPD.
No takes yet. Share an insight, caveat, or question.
Kiewa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: